Current Neuropharmacology
Title:Graphical Abstracts:
Volume: 12 Issue: 1
Export Options
About this article
Cite this article as:
Graphical Abstracts:, Current Neuropharmacology 2014; 12 (1) . https://dx.doi.org/10.2174/1570159X1201140117155544
DOI https://dx.doi.org/10.2174/1570159X1201140117155544 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting
Current Cancer Drug Targets Cell Immunity in Inflammatory Vasculitis
Current Immunology Reviews (Discontinued) Anorexia Nervosa and Comorbid Psychopathology
Endocrine, Metabolic & Immune Disorders - Drug Targets A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
Mini-Reviews in Medicinal Chemistry Preface [Hot topic: Potential Therapeutic Agents for Parkinsons Disease (Executive Editor: Masato Asanuma)]
Current Pharmaceutical Design Liver-Based In Vitro Technologies for Drug Biotransformation Studies - A Review
Current Drug Metabolism Characterisation of a Neural Teratogenicity Assay Based on Human ESCs Differentiation Following Exposure to Valproic Acid
Current Medicinal Chemistry Central Nervous System Abnormalities in Fibromyalgia and Chronic Fatigue Syndrome: New Concepts in Treatment
Current Pharmaceutical Design Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents
Current Medicinal Chemistry Frailty Among Alzheimer’s Disease Patients
CNS & Neurological Disorders - Drug Targets Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity
Central Nervous System Agents in Medicinal Chemistry The PD-1/PD-L1 Pathway in Human Pathology
Current Molecular Medicine Nuclear Magnetic Resonance Spectroscopy and Genetic Disorders
Current Medicinal Chemistry Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review
Current Drug Therapy Current Therapeutic Advances in Patients and Experimental Models of Huntington's Disease
Current Drug Targets Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses
CNS & Neurological Disorders - Drug Targets Transcranial Direct Current Stimulation in Psychiatric Disorders: A Comprehensive Review of Recent Advances
Current Psychiatry Reviews Editorial: Zebrafish Psychopharmacology
Current Psychopharmacology The Endocannabinoid System and Huntingtons Disease
Current Drug Targets - CNS & Neurological Disorders Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks
Current Pharmaceutical Design